封面
市场调查报告书
商品编码
1812421

胸膜切片检查市场按产品类型、程序、诊断用途、指导方法、最终用户和地区划分

Pleural Biopsy Market, By Product Type, By Technique, By Diagnostic Application, By Guidance Method, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年胸膜切片检查市场价值估计为 3.304 亿美元,预计到 2032 年将达到 5.034 亿美元,2025 年至 2032 年的复合年增长率为 6.2%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 3.304亿美元
效能数据 2020-2024 预测期 2020-2024
预测期间(2025-2032年)的复合年增长率: 6.20% 2032年预测 5.034亿美元

全球胸膜切片检查市场是诊断医疗保健领域的一个重要领域,涵盖从胸膜获取组织样本进行病理检查的程序和技术。胸膜切片检查是识别各种胸膜疾病的重要诊断工具,例如恶性肋膜间质细胞瘤、肺癌转移、结核病以及其他发炎性和感染性胸膜疾病。该市场涵盖多种操作方法,包括使用Abrams或Cope针进行的闭合性经皮切片检查、胸腔镜手术和CT引导下的经皮切片检查,每种方法在诊断准确性和患者安全性方面均具有独特的优势。

呼吸系统疾病的盛行率不断上升,加上环境中致癌性的暴露量不断增加,以及人们对早期疾病检测意识的不断增强,这些因素极大地推动了市场的成长。全球医疗保健系统正在大力投资先进的诊断技术,随着影像引导系统和微创技术的融合,胸膜切片检查程序也变得越来越复杂。切片检查仪器的技术进步、操作安全通讯协定的改进以及诊断准确性的提高,使得胸膜切片检查成为全球现代肺胸医学的重要组成部分。

市场动态

全球胸膜切片检查市场正经历强劲成长,这得益于多种相互关联的因素。肺癌和间皮瘤发生率的上升是主要的成长催化剂,尤其是在全球老化社会中,环境和职业暴露于石棉及其他致癌性的情况日益突出。新兴市场的技术创新,例如先进的影像引导切片检查系统、微创胸腔镜技术以及准确性和安全性更高的针吸活检设备的开发,是市场扩张的主要驱动力,因为它们能够提高诊断准确性并减少併发症。

随着医疗服务提供者日益重视早期疾病检测和个人化医疗,市场成长也进一步受到推动。他们越来越意识到采集高品质组织样本用于分子诊断和标靶治疗选择的重要性。全球胸膜切片检查市场正经历强劲增长,这主要归因于多种相互关联的因素,尤其是肺癌和间皮瘤发病率的上升,因为环境和职业暴露于石棉及其他致癌性持续影响全球老龄化人口,这成为主要的增长催化剂。

监管挑战和新切片检查设备的冗长核准流程也阻碍了市场成长。然而,新兴经济体医疗基础设施的扩张、医疗支出的增加、医疗旅游业的增长以及结合人工智慧和机器人辅助的下一代切片检查技术的发展,正在带来重大机会,这些机会有望提高手术准确性、减少併发症,并扩大胸膜切片检查程序的可用性和采用范围,使全球更广泛的患者群体受益。

本次调查的主要特点

  • 本报告对全球胸膜切片检查市场进行了详细分析,并以 2024 年为基准年,提供了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR%)。
  • 它揭示了各个领域的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、性能和策略等参数概述了全球胸膜切片检查市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
  • 全球胸膜切片检查市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球胸膜切片检查市场的各种策略矩阵更轻鬆地做出决策。

目录

第 1 章:调查目标与先决条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章:市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 抑制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020-2032 年全球胸膜切片检查市场(依产品类型)

  • 切片穿刺针和器械
  • 胸腔镜及配件
  • 成像和引导系统
  • 辅助器具(吸引器、镊子、套件等)

5. 2020-2032 年全球胸膜切片检查市场(依技术划分)

  • 针吸切片(闭式针/艾布拉姆斯针)
  • 胸腔镜胸膜切片检查(内科胸腔镜/VATS)
  • 开放性胸膜切片检查

6. 2020-2032 年全球胸膜切片检查市场(依诊断应用)

  • 恶性胸腔积水/恶性胸膜肿瘤(如间皮瘤、转移性癌症)
  • 感染性胸膜疾病(例如结核病、细菌性/真菌性胸膜炎)
  • 发炎和自体免疫疾病(例如类风湿性胸膜炎、红斑性狼疮)
  • 其他特发性或原因不明的胸腔积液

7. 2020-2032 年全球胸膜切片检查市场(依指导方法)

  • 影像引导(CT引导、超音波引导)
  • 无感

8. 2020-2032 年全球胸膜切片检查市场(依最终使用者划分)

  • 医院
  • 专科诊所
  • 诊断中心
  • 门诊手术中心
  • 学术和研究机构

9. 2020-2032 年全球胸膜切片检查市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十章 竞争格局

  • Olympus Corporation
  • Boston Scientific Corporation
  • Cook Medical
  • CONMED Corporation
  • Medtronic plc
  • Braun Melsungen AG
  • Hologic Inc.
  • BD(Becton, Dickinson and Company)
  • FUJIFILM Holdings Corporation
  • KARL STORZ SE & Co. KG
  • Ethicon(Johnson & Johnson)
  • Argon Medical Devices
  • Richard Wolf GmbH
  • Smiths Medical

第 11 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十二章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8455

Pleural Biopsy Market is estimated to be valued at USD 330.4 Mn in 2025 and is expected to reach USD 503.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 330.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.20% 2032 Value Projection: USD 503.4 Mn

The global pleural biopsy market represents a critical segment within the diagnostic healthcare landscape, encompassing procedures and technologies designed to extract tissue samples from the pleura for pathological examination. Pleural biopsy procedures serve as essential diagnostic tools for identifying various pleural conditions, including malignant pleural mesothelioma, lung cancer metastases, tuberculosis, and other inflammatory or infectious pleural diseases. The market encompasses multiple procedural approaches, including closed pleural biopsy using Abrams or Cope needles, thoracoscopic procedures, and CT-guided percutaneous biopsies, each offering distinct advantages in terms of diagnostic accuracy and patient safety.

The increasing prevalence of respiratory diseases, coupled with rising environmental exposure to carcinogenic substances and growing awareness of early disease detection, has significantly propelled market growth. Healthcare systems worldwide are witnessing substantial investments in advanced diagnostic technologies, with pleural biopsy procedures becoming increasingly sophisticated through integration of imaging guidance systems and minimally invasive techniques. The market's evolution is further driven by technological advancements in biopsy instruments, improved procedural safety protocols, and enhanced diagnostic accuracy, making pleural biopsy an indispensable component of modern pulmonary and thoracic medicine practices globally.

Market Dynamics

The global pleural biopsy market is experiencing robust growth, driven by multiple interconnected factors. The increasing incidence of lung cancer and mesothelioma serves as a primary growth catalyst, particularly as environmental and occupational exposures to asbestos and other carcinogenic substances continue to manifest in aging populations worldwide. Advanced technological innovations, including the development of sophisticated imaging-guided biopsy systems, minimally invasive thoracoscopic techniques, and enhanced needle biopsy instruments with improved precision and safety profiles, significantly drive market expansion by enabling more accurate diagnoses with reduced procedural complications.

The growing emphasis on early disease detection and personalized medicine approaches further accelerates market growth, as healthcare providers increasingly recognize the critical importance of obtaining high-quality tissue samples for molecular diagnostics and targeted therapy selection. The global pleural biopsy market is experiencing robust growth, driven by multiple interconnected factors. A key growth catalyst is the rising incidence of lung cancer and mesothelioma, especially as environmental and occupational exposures to asbestos and other carcinogenic substances continue to affect aging populations worldwide.

Regulatory challenges and lengthy approval processes for new biopsy devices also impede market growth. Nevertheless, significant opportunities emerge through expanding healthcare infrastructure in emerging economies, increasing healthcare expenditure, growing medical tourism, and the development of next-generation biopsy technologies incorporating artificial intelligence and robotic assistance, which promise to enhance procedural accuracy, reduce complications, and expand the accessibility of pleural biopsy procedures to broader patient populations globally.

Key Features of the Study

  • This report provides in-depth analysis of the global pleural biopsy market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pleural biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Olympus Corporation, Boston Scientific Corporation, Cook Medical, CONMED Corporation, Medtronic plc, B. Braun Melsungen AG, Hologic Inc., BD (Becton, Dickinson and Company), FUJIFILM Holdings Corporation, KARL STORZ SE & Co. KG, Ethicon (Johnson & Johnson), Argon Medical Devices, Richard Wolf GmbH, and Smiths Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pleural biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural biopsy market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Biopsy Needles and Instruments
    • Thoracoscopes and Accessories
    • Imaging and Guidance Systems
    • Ancillary Equipment (suction devices, forceps, kits, etc.)
  • Technique Insights (Revenue, USD Mn, 2020 - 2032)
    • Needle Biopsy (Closed Needle/Abrams Needle)
    • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Open Surgical Pleural Biopsy
  • Diagnostic Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Other Idiopathic or Unexplained Pleural Effusions
  • Guidance Method Insights (Revenue, USD Mn, 2020 - 2032)
    • Image-Guided (CT-guided, Ultrasound-guided)
    • Non-Guided
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Ambulatory Surgical Centers
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Olympus Corporation
    • Boston Scientific Corporation
    • Cook Medical
    • CONMED Corporation
    • Medtronic plc
    • Braun Melsungen AG
    • Hologic Inc.
    • BD (Becton, Dickinson and Company)
    • FUJIFILM Holdings Corporation
    • KARL STORZ SE & Co. KG
    • Ethicon (Johnson & Johnson)
    • Argon Medical Devices
    • Richard Wolf GmbH
    • Smiths Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pleural Biopsy Market, By Product Type
    • Global Pleural Biopsy Market, By Technique
    • Global Pleural Biopsy Market, By Diagnostic Application
    • Global Pleural Biopsy Market, By Guidance Method
    • Global Pleural Biopsy Market, By End User
    • Global Pleural Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Pleural Biopsy Market, By Product Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biopsy Needles and Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Thoracoscopes and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Imaging and Guidance Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ancillary Equipment (suction devices, forceps, kits, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Pleural Biopsy Market, By Technique, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Needle Biopsy (Closed Needle/Abrams Needle)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Open Surgical Pleural Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Pleural Biopsy Market, By Diagnostic Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Idiopathic or Unexplained Pleural Effusions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Pleural Biopsy Market, By Guidance Method, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Image-Guided (CT-guided, Ultrasound-guided)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Non-Guided
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Pleural Biopsy Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Pleural Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive landscape

  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CONMED Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD (Becton, Dickinson and Company)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KARL STORZ SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Argon Medical Devices
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Richard Wolf GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Smiths Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us